Lmr Partners LLP Alkermes Plc. Put Options Transaction History
Lmr Partners LLP
- $10.9 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
366Shares Held
176MCall Options Held
196KPut Options Held
118K-
Black Rock Inc. New York, NY29.1MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$666 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$468 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$317 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$272 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.91B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...